Literature DB >> 16114177

Pediatric epilepsy surgery: lessons and challenges.

Deepak K Lachhwani1.   

Abstract

Pediatric epilepsy surgery has come of age, from being considered as a last resort in medically refractory focal epilepsy, after failure of numerous antiepileptic drug trials spanning many years, to a preferred treatment option in carefully selected candidates. There have been certain key developments that have catalyzed this change. First, we are able to predict medical intractability earlier during the course of epilepsy. Second, improved understanding of how the maturing brain recovers from neurologic insults has led to earlier consideration of surgical intervention during a window of developmental plasticity. Finally, improved diagnostic and surgical capabilities now enable us to identify more candidates suitable for surgery. At the same time, as the surgical frontier has been rapidly pushed to new horizons, we have also unearthed new challenges. In this review, several pediatric epilepsy syndromes are discussed to highlight these important developments.

Entities:  

Mesh:

Year:  2005        PMID: 16114177     DOI: 10.1016/j.spen.2005.04.001

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  3 in total

Review 1.  Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy.

Authors:  R Kneen; R E Appleton
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

Review 2.  Present status of surgical intervention for children with intractable seizures.

Authors:  Dewi T Depositario-Cabacar; James J Riviello; Masanori Takeoka
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

3.  Subtraction Ictal SPECT coregistered to MRI (SISCOM) as a guide in localizing childhood epilepsy.

Authors:  Thomas Foiadelli; Lieven Lagae; Karolien Goffin; Tom Theys; Mara De Amici; Lucia Sacchi; Johannes Van Loon; Salvatore Savasta; Katrien Jansen
Journal:  Epilepsia Open       Date:  2019-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.